---
content_type: resource
description: Gleevec (in red) is a drug used to treat chronic myeloid leukemia (CML).
  It works by inhibiting bcr-abl kinase (in green), the protein that causes CML. (Image
  courtesy of RCSB Protein Data Bank entry 1IEP.)
file: null
file_location: /coursemedia/7-341-bench-to-bedside-molecularly-targeted-therapies-in-blood-disorders-and-malignancy-fall-2009/9418486610e6ecaf57c0a5d752c7864f_7-341f09.jpg
file_type: image/jpeg
resourcetype: Image
title: Ribbon diagram of the crystal structure of BCR-ABL kinase in complex with Gleevec
uid: 94184866-10e6-ecaf-57c0-a5d752c7864f
---
